Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing

Autor: Maria Elena Avale, Jean-Marc Gallo, Teresa Rodriguez-Martin
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Trans-splicing
Trans-Splicing
purl.org/becyt/ford/1 [https]
Mice
Exon
0302 clinical medicine
Gene Order
RNA Precursors
Protein Isoforms
Genetics (clinical)
Neurons
0303 health sciences
biology
Gene Transfer Techniques
Brain
Articles
General Medicine
purl.org/becyt/ford/3.1 [https]
Bioquímica y Biología Molecular
Medicina Básica
RNA splicing
purl.org/becyt/ford/3 [https]
Tauopathy
CIENCIAS NATURALES Y EXACTAS
CIENCIAS MÉDICAS Y DE LA SALUD
Genetic Vectors
Tau protein
Genética Humana
Mice
Transgenic

tau Proteins
Cell Line
Ciencias Biológicas
03 medical and health sciences
Gene therapy
mental disorders
Genetics
medicine
Animals
Humans
Neurodegeneration
purl.org/becyt/ford/1.6 [https]
Molecular Biology
030304 developmental biology
Messenger RNA
Lentivirus
Alternative splicing
RNA
medicine.disease
Molecular biology
Protein Biosynthesis
biology.protein
030217 neurology & neurosurgery
Zdroj: CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Human Molecular Genetics
Popis: Abnormal metabolism of the tau protein is central to the pathogenesis of a number of dementias, including Alzheimer's disease. Aberrant alternative splicing of exon 10 in the tau pre-mRNA resulting in an imbalance of tau isoforms is one of the molecular causes of the inherited tauopathy, FTDP-17. We showed previously in heterologous systems that exon 10 inclusion in tau mRNA could be modulated by spliceosome-mediated RNA trans-splicing (SMaRT). Here, we evaluated the potential of trans-splicing RNA reprogramming to correct tau mis-splicing in differentiated neurons in a mouse model of tau mis-splicing, the htau transgenic mouse line, expressing the human MAPT gene in a null mouse Mapt background. Trans-splicing molecules designed to increase exon 10 inclusion were delivered to neurons using lentiviral vectors. We demonstrate reprogramming of tau transcripts at the RNA level after transduction of cultured neurons or after direct delivery and long-term expression of viral vectors into the brain of htau mice in vivo. Tau RNA trans-splicing resulted in an increase in exon 10 inclusion in the mature tau mRNA. Importantly, we also show that the trans-spliced product is translated into a full-length chimeric tau protein. These results validate the potential of SMaRT to correct tau mis-splicing and provide a framework for its therapeutic application to neurodegenerative conditions linked to aberrant RNA processing. Fil: Avale, Maria Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular; Argentina. Institute of Psychiatry. King’s College London. Centre for Neurodegeneration Research. Department of Clinical Neuroscience; Reino Unido Fil: Rodrigez Martin, Teresa. Institute of Psychiatry. King’s College London. Centre for Neurodegeneration Research. Department of Clinical Neuroscience; Reino Unido Fil: Gallo, Jean-Marc. Institute of Psychiatry. King’s College London. Centre for Neurodegeneration Research. Department of Clinical Neuroscience; Reino Unido
Databáze: OpenAIRE